Detalhe da pesquisa
1.
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Oncologist
; 21(6): 762-70, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245569